M
Power Law company profile
Medexus Pharmaceuticals
Biotech & Life Sciences · Montreal, Canada · Founded 2007 · IPO 2012 Thoroughbred
Valuation
$104M
Market cap · May/2026
Revenue
$108M
Latest reported FY
EBITDA
$16M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Investors
1 investor on Medexus Pharmaceuticals's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series B+
1 investor entered at this stage
Global footprint
Where Medexus Pharmaceuticals has talent and traffic
Workforce by country
4
countries with
team presence
team presence
🇺🇸 United States57.7%
🇨🇦 Canada39.4%
🇦🇪 United Arab Emirates1.4%
🇪🇸 Spain1.4%
Web traffic by country
4.8K
monthly visits
across markets
across markets
🇨🇦 Canada60.4%
🇺🇸 United States47.9%
🇮🇳 India4.2%
Market sentiment
What the market is saying about Medexus Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Medexus Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medexus Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.